tirzepatide cancer risk Not 👏 A 👏 Fad ! 👏 Notice these trials are all using ?!, There are active and recently opened clinical/human trials (& more coming !) testing tirzepatide in breast-cancer populations. Why ? Tirzepatide—Friend or Foe in Diabetic

With the direct-to-consumer pharmacy, the way that works is we are contracting directly with the manufacturers [and] the consumers coming directly to us, Rechtin said Thursday

Glucagon-like peptide-1 or GLP-1 medications were first approved for weight loss in 2014 and Wegovy was approved for weight loss in 2021

Those who have successfully implemented sustainable changesincluding regular physical activity (UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity activity weekly), improved dietary patterns, and behavioural strategies for weight managementmay have better outcomes if discontinuing GLP-1 therapy

10.1007/s12011-022-03453-7 [DOI] [PubMed] 36.Wang F, Sun N, Zeng H, et al

Medication is not a replacement for healthy habits